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Abstract
Candida albicans is the major fungal pathogen of humans. Its adhesion to host-cell surfaces is the first critical step during
mucosal infection. Antimicrobial peptides play important roles in the first line of mucosal immunity against C. albicans
infection. LL-37 is the only member of the human cathelicidin antimicrobial peptide family and is commonly expressed in
various tissues, including epithelium. We previously showed that LL-37 significantly reduced C. albicans adhesion to plastic,
oral epidermoid OECM-1 cells, and urinary bladders of female BALB/c mice. The inhibitory effect of LL-37 on cell adhesion
occurred via the binding of LL-37 to cell-wall carbohydrates. Here we showed that formation of LL-37–cell-wall protein
complexes potentially inhibits C. albicans adhesion to polystyrene. Using phage display and ELISA, we identified 10 peptide
sequences that could bind LL-37. A BLAST search revealed that four sequences in the major C. albicans cell-wall b-1,3-
exoglucanase, Xog1p, were highly similar to the consensus sequence derived from the 10 biopanned peptides. One Xog1p-
derived peptide, Xog1p90–115, and recombinant Xog1p associated with LL-37, thereby reversing the inhibitory effect of LL-
37 on C. albicans adhesion. LL-37 reduced Xog1p activity and thus interrupted cell-wall remodeling. Moreover, deletion of
XOG1 or another b-1,3-exoglucanase-encoding gene EXG2 showed that only when XOG1 was deleted did cellular
exoglucanase activity, cell adhesion and LL-37 binding decrease. Antibodies against Xog1p also decreased cell adhesion.
These data reveal that Xog1p, originally identified from LL-37 binding, has a role in C. albicans adhesion to polystyrene and,
by inference, attach to host cells via direct or indirect manners. Compounds that target Xog1p might find use as drugs that
prevent C. albicans infection. Additionally, LL-37 could potentially be used to screen for other cell-wall components involved
in fungal cell adhesion.
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Introduction
Candida albicans is an opportunistic pathogenic yeast that
commonly colonizes mucosal surfaces and can cause severe blood
infections in immunocompromised individuals [1,2]. Interaction
between C. albicans and epithelial cells is necessary for disease
development and progression. Initially, C. albicans adheres to and
colonizes epithelial cell surfaces prior to invading and disrupting
the cells [3]. C. albicans expresses various cell-wall components that
facilitate cell adhesion [4]. As a counter to C. albicans infection,
epithelial cells first produce antimicrobial compounds, e.g.,
defensins, cathelicidins, and histatins, which can kill the fungus
or prevent its adhesion to host cells [5,6,7].
Cathelicidins are antimicrobial peptides that contain a highly
conserved cathelin domain and a highly variable cathelicidin
domain [8]. For human cathelicidin, proteinase-3 cleaves its C-
terminal region, thereby generating the mature, active 37-residue
antimicrobial peptide LL-37 [9] that contains two leucine residues
(LL) at the N terminus [10]. LL-37 is positively charged at neutral
pH, contains many hydrophobic and basic residues, and is a-
helical. These properties allow LL-37 to bind and disrupt the
negatively charged membranes of pathogens, leading to cell death
[11,12]. LL-37 is produced by neutrophils, macrophages, mucosal
epithelial cells, and keratinocytes [13], which suggests that it is part
of the innate immunity system, protects against infection, and
participates in the inflammatory response [14]. In addition to its
antimicrobial and cytotoxic activities, LL-37 also functions in
leukocyte chemotaxis, endotoxin neutralization, inhibition of
microbial adhesion, and wound healing at epithelial surface
[15,16,17,18]. LL-37 acts by interacting with microbial cell walls,
the plasma membrane, cellular proteins, and DNA [7,19,20,21].
The C. albicans cell wall is a dynamic and highly regulated
structure that forms the outermost layer of the cell, thus
maintaining cell shape and integrity and interacting with host
cells and the surrounding environment [22]. It contains the
polysaccharides glucan, chitin, and mannans, which form the
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or lipids and represent 35–40% of the total cell-wall polysaccha-
rides [23,24]. Cell-wall proteins (CWPs) function during cell-wall
assembly and remodeling, adhesion to a host or an abiotic surface,
biofilm formation, invasion of epithelia, and as part of the escape
mechanism from the host immune system [25,26,27,28]. Except
for certain heat-shock proteins and glycolytic enzymes, most
external coat of CWPs are glycosylphosphatidylinositol (GPI)
proteins that are often highly mannosylated and phosphorylated
[25,29,30]. In Saccharomyces cerevisiae, disulfide bridges of the
external protein coat affect cell wall permeability [31]; this may
be also the case in C. albicans, suggesting that GPI-CWPs might be
interconnected by disulfide bonds [25]. In addition, CWPs can be
released from intact cells by reducing agents [32], it is assumed
that CWPs are linked to other CWPs by disulfide bridges [24].
The cell-wall enzymes include glucanases, chitinases, peptidases,
and glycotransferases that are involved in cell-wall synthesis and
remodeling, thus providing flexibility and strength to the cell wall
during cell growth or lysis in response to a stress [33,34,35].
Because the structural complexity of the cell-wall components is
crucial to C. albicans physiology, targeting the integrity or functions
of its cell wall is an excellent way to interfere with infection
processes, such as cell adhesion [36].
b-1,3-glucan and b-1,6-glucan are the major structural
components of the C. albicans cell wall and account for 40% and
20% of the cell-wall components, respectively. The flexible, three-
dimensional cell-wall network is composed of b-1,3-glucan [24]. In
S. cerevisiae, glucanases remodel the glucan network by nicking the
glucans and introducing branch points [37]. In C. albicans, three
related exo-b-1,3-glucanases, Xog1p, Exg2p, and Spr1p, hydro-
lytically remove glucose from the ends of cell-wall glucans
[35,38,39]. The purpose of C. albicans Spr1p has yet to be
determined, although in S. cerevisiae it is specifically expressed
during sporulation [40,41]. Exg2p is present during C. albicans cell-
wall regeneration [40,41]. Xog1p is the major exo-1,3-b-glucanase
associated with the C. albicans periplasmic cell wall. It is a non-
glycosylated protein with a molecular mass of ,45 kDa, which is
also the approximate mass of Exg2p and Spr1p, and its sequence is
58% identical to that of S. cerevisiae Exg1p [42,43,44]. Although
Xog1p is responsible for cell-wall construction and remodeling
[45], it may have additional roles that need to be delineated.
For the study reported herein, we identified and characterized
an interaction between LL-37 and C. albicans Xog1p that adversely
affects C. albicans adhesion. We found that LL-37 binding to
Xog1p diminished the glucanase activity of Xog1p and signifi-
cantly reduced C. albicans attachment to polystyrene. Moreover,
Xog1p itself was shown to be directly or indirectly involved in C.
albicans adhesion. Therefore, drugs that target Xog1p might be
used to prevent C. albicans adhesion. Furthermore, LL-37 could
perhaps be used to screen for other cell-wall molecules involved in
C. albicans adhesion to substrata.
Results
Binding of LL-37 to C. albicans CWPs
In our previous study we found that LL-37 inhibited the
adhesion of C. albicans to polystyrene by binding to cell-wall
polysaccharides, in particular, mannan [21]. However, after
removal of ,50% of the carbohydrates from the cell wall, the
amount of LL-37 bound to C. albicans was reduced by only ,30%
as compared with the amount bound to control (non-deglycosy-
lated) cells [21]. In addition to the high carbohydrate content of
the C. albicans cell wall, proteins represent 20,30% of the total
mass [33]. Therefore, we could not exclude the possibility that LL-
37 interacts with CWPs. To test this hypothesis, the binding of
biotinylated LL-37 (BA-LL37) to C. albicans was assessed. For the
removal of proteinacous layer, C. albicans cells were preincubated
with proteinase K followed by treatment with BA-LL37. BA-LL37
bound to these cells was assessed using flow cytometry in
conjunction with SA-4,6-dichlorotriazinyl aminofluorescein (SA-
DTAF) detection [21]. Given the fluorescence intensities measured
(Fig. 1A, upper panels), it was apparent that BA-LL37 bound to C.
albicans. In contrast, after removing cell-wall proteins with
proteinase K, the binding of BA-LL37 was almost abolished
Figure 1. Binding of LL-37 to C. albicans cell-wall proteins. (A) Flow cytometry showing that BA-LL37 bound to C. albicans. Cells were treated
with 1 mg/ml proteinase K (lower panels) or were not treated (upper panels) prior to incubation with 10 mg BA-LL37. The fluorescence intensity (FL1-
H) of SA-DTAF that was associated with the cells via binding to BA-LL37 was measured to determine the amount of BA-LL37 bound to cells. The
results are representative of two independent experiments that gave similar results. (B) Extracts prepared by fractionation of C. albicans cell-wall
proteins using b-ME and b-glucanase. The proteins in the extracts were separated by SDS-PAGE and transferred to a polyvinylidene difluoride
membrane. The membranes were probed with BA-LL37 and visualized with HRP–conjugated streptavidin. Arrows indicate the three major cell wall
proteins bound by LL-37. The positions and values of molecular mass standards are indicated. Data are representative of three independent
experiments that gave similar results.
doi:10.1371/journal.pone.0021394.g001
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were isolated, and LL-37 binding was demonstrated by far-western
blotting using BA-LL37 as the probe. Several CWPs from an
extract prepared from b-mercaptoethanol (b-ME)-treated cells
bound BA-LL37, particularly two proteins with molecular masses
of 45–50 kDa and a third protein with a mass of ,60 kDa
(Fig. 1B). However, LL-37 did not appear to specifically bind
proteins in an extract prepared from b-glucanase-treated cells
(Fig. 1B). Therefore, only the b-ME extract was examined further.
These results indicate that LL-37 interacts with both cell-wall
polysaccharides [21] and proteins.
Xog1p: an LL-37-binding target identified by phage-
display biopanning
To identify which C. albicans CWPs were targeted by LL-37,
phage-display biopanning was performed using a linear dodeca-
peptide library and LL-37. After three rounds of biopanning, 20
phage clones had been amplified and were characterized by DNA
sequencing and ELISA, the results of which indicated that 10
clones could bind LL-37. Although the extent of LL-37 binding
varied, these clones contained the consensus peptide sequence
WHWXWWXWXW, where W is a hydrophobic residue and X
represents any residue (Fig. 2). This consensus sequence was used
in candidates to identify potential LL-37-binding proteins in the
Candida Genome Database (www.candidagenome.org). Among the
potential binding targets identified, Xog1p was chosen for further
characterization because it has a molecular mass of ,45 kDa,
which is similar to that for one of the CWPs identified by far-
western blotting (Fig. 1B) and because Xog1p is the major exo-b-
1,3-glucanase involved in C. albicans cell-wall remodeling and
assembly [45]. Interestingly, four peptide sequences in Xog1p
matched well with those of the phage-display and were therefore
predicted to be possible LL-37 recognition and binding sites
(Fig. 2). These data suggested that Xog1p is a potential LL-37
target.
LL-37 associates with Xog1p
Because there were four potential LL-37 recognition/binding
sequences in Xog1p (Fig. 2), we also mapped these sequences to
the Xog1p three-dimensional structure [46]. Two of the peptide
sequences (residues 90–93 and 108–112, Fig. 2) are at the surface
[46]. A short peptide containing residues 90–115 (Xog190–115) was
synthesized and used in the LL-37-binding/ELISA assay. LL-37
bound Xog190–115 in a dose-dependent and saturable manner
(Fig. 3A).
To characterize LL-37-Xog1p binding, we expressed a soluble
His-tagged recombinant Xog1p (rXog1p) and produced rat
polyclonal antibodies against Xog1p for use in western blotting.
Figure 2. Identification of potential LL-37-binding peptides by phage display. Twenty phage clones were isolated after three rounds of
biopanning. The interaction between 10 of the phage-displayed peptides and LL-37 was confirmed by ELISA. The phage samples were added into LL-
37-pre-coated plates for binding, and after removing unbound phages, the phage/LL-37 complexes were stained with anti-M13 and detected using
an ELISA reader. Those sequences for which the A450 was .0.05 are shown in the figure. The 10 sequences are aligned. Identical residues are in red,
residues with similar physicochemical properties are in magenta, and the consensus sequence is in blue. X indicates any amino acid, and W indicates a
hydrophobic residue. The consensus sequence is aligned with four sequences found in Xog1p at the bottom of the figure. Residues in the peptides
that are homologous with or identical to residues in the consensus sequence are in brown.
doi:10.1371/journal.pone.0021394.g002
Xog1p in C. albicans Adhesion
PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e21394The expression and purification of rXog1p was confirmed by
western blotting with anti-His6 (Fig. 3B, left panel). Moreover,
rXog1p had exoglucanase activity (data not shown), and anti-
Xog1p recognized rXog1p (Fig. 3B, right panel). b-ME cell-wall
extracts were also examined by western blotting. BA-LL37 bound
to a protein of 45 kDa that co-migrated with rXog1p and was
recognized by anti-Xog1p (Fig. 3C). BA-LL37 was then used as
bait in pull-down assays under native conditions. BA-LL37 pulled
down full-length rXog1p, and this complex was distinguishable
from BA-LL37 (Fig. 3D). Together, these results strongly suggested
that Xog1p is an LL-37-binding target that resides on the C.
albicans cell wall.
Roles of Xog1p in LL-37-mediated inhibition of C.
albicans adhesion
We previously showed that LL-37 inhibits C. albicans adhesion to
polystyrene by binding to the cells with increasing LL-37
concentrations starting from 0.1 to 20 mg/ml [21]. We tested if
Xog190–115 could also block LL-37 binding to Xog1p and thereby
compensate reduction of cell adhesion. LL-37 was mixed with
Xog190–115, added to C. albicans cells, and then the 2,3-bis-(2-
methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide
(XTT)-reduction assay was performed. At 5 mg/ml (,1.1 mM)
LL-37, the adhesion inhibition mediated by LL-37 was ,70%
(Fig. 4A) which was consistent with our previous finding [21].
Xog190–115 prevented LL-37 inhibition of cell adhesion in a
dose-dependent manner when the concentration of Xog190–115
was at least 0.1375 mM (Fig. 4A). Therefore, LL-37 may
interact with cell-wall Xog1p and thereby reduce C. albicans
adhesion. Additionally, rXog1p was tested in the C. albicans
adhesion assay to determine if it could reverse the inhibitory
effect of LL-37. As expected, LL-37 reduced the adhesion of C.
albicans to polystyrene, whereas rXog1p rescued the LL-37-
induced inhibition of cell adhesion (Fig. 4A).
Xog1p is the major C. albicans cell-wall exoglucanase [45].
Disruption of C. albicans XOG1, which encodes Xog1p, alters the
cell-wall composition and changes the susceptibility of C. albicans
to antifungal agents that inhibit b-(1,3)-glucan synthesis [45] or
chitin biosynthesis [47]. We therefore considered the possibility
that LL-37-mediated inhibition of cell adhesion may be the result
of disrupted cell-wall remodeling. Cell adhesion to a substratum
may alter the framework of the cell wall. Therefore, it was
important to determine if Xog1p activity could be affected by LL-
37. We assayed the in vitro exoglucanase activity in cell-free
extracts from logarithmically growing C. albicans. Xog1p activity
decreased as the LL-37 concentration increased (Fig. 4B),
implying that the assembly of the cell-surface glucan network
might be altered by a decrease in Xog1p activity, which might
Figure 3. Expression of full-length Xog1p and its interaction with LL-37. (A) ELISA for the binding of Xog190–115 to LL-37. Wells were coated
with 5 mg of Xog190–115 and then incubated with different concentrations of BA-LL37 at room temperature for 1 h. Binding was detected with SA-
HRP. All assays were performed in triplicate and carried out four times. A representative experiment is shown. Each value is the mean 6 the SD of the
absorbance recorded for one experiment. The statistical significance for the binding of treated vs. control wells was determined using Student’s t-test
(*, p,0.05). (B) Analysis of rXog1p and anti-Xog1p serum. Western blots of purified rXog1p using anti-Xog1p (right panel) or anti-His6 (left panel) as
probe. Mock is His-tagged recombinant D-amino acid oxidase. The positions of molecular mass standards (kDa) are indicated. (C) Western blots of
rXog1p and the b-ME cell-wall extract (CWP) from wild type and the xog1 mutant strain. rXog1p and CWP were probed with BA-LL37 (left panel) or
anti-Xog1p (right panel). (D) Pull-down assay for LL-37-rXog1p binding. Purified rXog1p was incubated with BA-LL37 and streptavidin-agarose beads
for 2 h at room temperature. The complexes were isolated by centrifugation, washed to remove non-specific BA-LL37-binding proteins, and
subjected to SDS-PAGE. rXog1p was visualized by Coomassie Blue staining.
doi:10.1371/journal.pone.0021394.g003
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remodeling was reflected in increased susceptibilities to different
agents that interrupt cell-wall integrity. The viability of LL-37-
treated cells on agar plates that contained such an agent, i.e.,
congo red and calcofluor white, decreased in comparison with
those cultured in the absence of such agents (Fig. 4C), indicating
that cell-wall remodeling had been altered and possibly inhibited
by LL-37. Therefore, the binding of LL-37 to Xog1p might
indirectly interfere with cell adhesion by interrupting cell-wall
assembly.
Xog1p is involved in C. albicans adhesion
Given that LL-37 inhibited cell adhesion by binding Xog1p,
Xog1p itself might be involved in the adhesion process via direct
or indirect manners. To further explore the role of Xog1p in cell
adhesion, XOG1 heterozygous- and homozygous-deletion mutants
Figure 4. Xog1p plays a role in LL-37-mediated inhibition of C. albicans adhesion. (A) Assessment of the abilities of Xog190–115 (white bars)
and rXog1p (black bars) to rescue LL-37-mediated inhibition of C. albicans adhesion to polystyrene. Cells were incubated with 1.1 mM LL-37 and
different concentrations of Xog190–115 or rXog1p. Reduction of XTT was measured to assess the number of cells that adhered to the polystyrene wells.
The data were normalized to the corresponding control experiment (no LL-37) and are reported as a percentage. The right-most bars report the
results for cells incubated with only Xog190–115 or rXog1p. Each result is the average of three experiments, each performed in triplicate. The two-tailed
Student’s t-test was used to determine the statistical significance of the data (1, p,0.01 for LL-37-treated cells vs. control cells; *, p,0.05 and **,
p,0.01 for LL-37-treated cells in the presence of Xog190–115 or rXog1p vs. cells treated only with LL-37). (B) Exoglucanase activity in cell-free extracts
of wild type C. albicans. Cells were incubated with different concentrations of LL-37 in RPMI-1640 at 37uC for 30 min, and then cell-free extracts were
prepared. Exoglucanase activity was assayed using the model substrate PNPG and expressed as a percentage. Assays were performed in
quadruplicate. (C) Susceptibilities of LL-37-treated cells to cell-wall-interrupting agents were demonstrated by spot assays on YPD plates. Upper
panel, controls; middle panel, 15 mg/ml congo red; bottom panel, 10 mg/ml calcofluor white. C. albicans was treated with different concentrations of
LL-37, and ten-fold serial dilutions of the cells were spotted onto the plates. These results are representative of three independent experiments that
gave similar results.
doi:10.1371/journal.pone.0021394.g004
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method [48]. Polymerase chain reaction (PCR; data not shown)
and Southern and western blotting (Fig. 5A) showed that the strain
constructs were as expected. For Southern blotting, genomic DNA
was digested with PstI and EcoRI and hybridized to a probe that
contained the 0.4-kb P
32-labeled DNA fragment upstream of
XOG1. Nucleotide fragments of 4.2 and 3.8 kb, which were the
expected lengths for the wild type and reintegrated XOG1
fragments, and a 2.2-kb band, which was the expected length
for the deleted XOG1 fragment, were found in the Southern blot
(Fig. 5A, upper panel). For western blotting, CWPs were isolated
from C. albicans grown in RPMI-1640 medium at 37uC for 30 min.
Xog1p from wild type cells was detected by anti-Xog1p but was
not detected in the extract of the xog1D/xog1D strain (Fig. 5A,
lower panel and Fig. 3C). Furthermore, we measured exogluca-
nase activity in the wild type and XOG1-deletion strains from
overnight cultures using the model substrate p-nitrophenyl b-D-
glucopyranoside (PNPG) [45]. Deletion of XOG1 resulted in a
significant reduction (,80%) in the hydrolysis of PNPG compared
with wild type cells (Fig. 5B). Interestingly, the XOG1/xog1D and
xog1D/xog1D::XOG1 strains displayed an intermediate phenotype
(Fig. 5B), indicating that deletion of a single allele decreased
glucanase activity.
Because cell adhesion is the first critical step during C. albicans
infection, we examined the involvement of Xog1p in adhesion. As
indicated, homozygous deletion of XOG1 reduced C. albicans
adhesion to polystyrene by ,20% (Fig. 5C). Conversely, the
xog1D/xog1D::XOG1 strain adhered to polystyrene to a similar
extent as the XOG1/xog1D heterozygous mutant. The strain in
which both XOG1 alleles were reintegrated behaved as the wild
type strain did (Fig. 5C). Binding of BA-LL37 to the wild type and
the deletion strains was also measured. The heterozygous and
homozygous strains showed a 30,40% decrease in their ability to
bind BA-LL37 as compared with the wild type strain. The XOG1-
reintegrated strain bound BA-LL37 as well as the wild type strain
(Fig. 5D). Collectively, these data indicated that Xog1p may play a
role in C. albicans adhesion and is one of the binding targets of LL-
37.
Because deletion of XOG1 did not completely abolish cell
adhesion to polystyrene and cell binding to LL-37, it is possible
that compensatory mechanisms were triggered to rescue the XOG1
deficiency, i.e., when XOG1 was deleted, other exoglucanases
might have been overexpressed. Therefore, exoglucanase activity
was measured in cell-free extracts from logarithmic–growth phase
wild type, XOG1-deletion, and reintegrated strains. Deletion of
both XOG1 alleles resulted in an ,30% decrease in glucanase
activity compared with that of wild type cells (Fig. 5E). During the
logarithmic-growth phase, homozygous deletion of XOG1 did not
cause as dramatic a reduction in exoglucanase activity as when the
cells were in the stationary phase (,80% reduction, Fig. 5B),
suggesting that other exoglucanases function in the rapid growing
cells requiring cell-wall assembly.
A search of the C. albicans genome database identified an
exoglucanase-encoding gene, EXG2, which is induced during cell-
wall regeneration [35,41]. To determine if Exg2p, encoded by
EXG2, is also involved in C. albicans cell adhesion, EXG2-deletion
mutants were constructed and verified by PCR (Fig. 6A, upper
panel) and reverse-transcription PCR (Fig. 6A, lower panel).
Interestingly, in contrast to the deletion of XOG1, EXG2 deletion
did not significantly reduce C. albicans adhesion (Fig. 6B) or LL-37
cell binding (Fig. 6C). Deletion of EXG2 did not reduce glucanase
activity (Fig. 6D), in agreement with the cell-adhesion and LL-37-
binding data (Fig. 6B and 6C), i.e., Exg2p is not heavily involved
in exoglucanase function in adhesion process of C. albicans.T o
exclude a possible compensatory effect in XOG1 mutant strains
after cultivation, a purified IgG-enriched fraction from anti-Xog1p
serum was tested for its ability to inhibit the adhesion of wild type
cells to polystyrene. We suspect that anti-Xog1p serum might act
similarly as LL-37, which inhibits adhesion of C. albicans through
directly binding with Xog1p or indirectly declining the glucanase
activity of Xog1p. The anti-Xog1p serum inhibited ,60% of the
cell adhesion to polystyrene compared with pre-immune or anti-C.
albicans serum (Fig. 7). Together, these results suggested that
Xog1p is targeted by LL-37 and is involved in C. albicans adhesion.
Discussion
Antimicrobial peptides are vital for epithelial host defense. As
the only antimicrobial peptide of the human cathelicidin family,
LL-37 defends the epithelium against microbes by several different
ways, including its constitutive expression by epithelial cells in the
absence of microbes, increasing its production and secretion in the
presence of microbes, directly killing nearby microbes, inhibiting
microbial adhesion to the epithelium, and recruitment of
neutrophils to secrete more LL-37 complementary to the epithelial
sources [49]. To date, the diverse effects of LL-37 have focused on
bacterial infection. Foschiatti et al. [50] demonstrated an
interaction between LL-37 and bacterial exopolysaccharides.
Bergsson et al. reported that LL-37 associates with glycosamino-
glycans in lung fluid from cystic fibrosis patients [51]. These
carbohydrates/LL-37 complexes neutralize the antimicrobial
activity of LL-37 [50,51]. Although it is well documented that
epithelium-derived LL-37 substantially protects against bacterial
infection, less is known about the action of LL-37 against fungal
pathogens.
We recently reported the first study showing that LL-37
interferes with fungal adhesion by documenting that sublethal
doses of LL-37 inhibit C. albicans adhesion to polystyrene, oral
epithelial cells, and mouse urinary bladder [21]. We provided
evidence that LL-37 partially inhibits C. albicans adhesion by
interacting with cell-wall carbohydrates and suggested that LL-37
may also interact with proteins, which are a major component of
the C. albicans cell wall. To test this hypothesis, for the study
reported herein, we used phage display and other approaches to
identify C. albicans surface proteins that can bind LL-37. We
demonstrated that LL-37 binds Xog1p (Fig. 3). The binding of
antimicrobial peptides to microbial surface proteins has been
reported previously. In the anaerobic bacteria Finegoldia magna, the
F. magna adhesion factor binds LL-37 and blocks its killing activity,
allowing F. magna to proliferate in humans [52]. LL-37 also
interacts with Escherichia coli curli fibers, which inhibits their self-
polymerization and thereby prevents E. coli cell adhesion to
substrata and biofilm formation [53]. Human b-defensin-3 binds
to immobilized recombinant hemagglutinin B, a nonfimbrial
adhesin from Porphyromonas gingivalis, thereby preventing adhesion
of the bacterium to host tissues [6,54]. Moreover, the C. albicans
cell-wall Ssa1p and Ssa2p chaperones bind and help import of
salivary histatin 5, which is required for toxicity [55].
C. albicans expresses surface glycans and proteins that act as
adhesins and other binding proteins to contract with substrates [4].
Several C. albicans adhesins are reported, including the Als and
Hwp1 proteins [56]. Notably, many cell-wall-associated enzymes
are also involved in cell adhesion. Camp65, a 65-kDa mannopro-
tein, is believed to be a b-endoglucanase, is a possible target of the
host immune response, and has adhesive properties [57]. The
endoglucanase activity of Camp65 contributes to cell-wall
degradation and remodeling [58]. The secreted aspartate
proteinases (Saps) of C. albicans, Sap1p, Sap2p, and Sap3p, are
Xog1p in C. albicans Adhesion
PLoS ONE | www.plosone.org 6 June 2011 | Volume 6 | Issue 6 | e21394Figure 5. XOG1 deletion reduces C. albicans adhesion to polystyrene and decreases cell association with LL-37. (A) Analysis of the
construction of the XOG1 deletion and reintegrated strains. For Southern blotting (upper panel), enzyme-digested chromosomal DNA was subjected
to agarose gel electrophoresis and transferred to a nylon membrane. The membrane was probed with a 0.44-kb, P
32-labeled DNA fragment
containing a C. albicans XOG1 upstream sequence. For western blotting (lower panel), a b-ME cell-wall extract and rXog1p were used. Equal volumes
of protein were subjected to SDS-PAGE and then detected with rat polyclonal anti-Xog1p. (B) Exoglucanase activity assay for various C. albicans
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PLoS ONE | www.plosone.org 7 June 2011 | Volume 6 | Issue 6 | e21394involved in the adhesion to buccal epithelial cells [59]. Xog1p is
secreted into the cell wall where it acts to breakdown b-1,3-glucan
during cell-wall remodeling [44]. In our study, interaction of LL-
37 and cell-wall Xog1p reduced C. albicans adhesion to polystyrene
(Fig. 4A), possibly because LL-37 indirectly decreased Xog1p
activity (Fig. 4B), thereby preventing cell-wall assembly (Fig. 4C).
Moreover, the xog1D/xog1D strain had reduced adhesion to
polystyrene (Fig. 5C) and attenuated exoglucanase activity
(Fig. 5E). Anti-Xog1p serum inhibited ,60% of the C. albicans
adhesion to polystyrene (Fig. 7). Together, these results strongly
suggest that Xog1p may be directly or indirectly involved in the
process of C. albicans adhesion. Torosantucci et al. suggested that an
antibody against b-1,3-glucan might be used to inhibit fungal
growth and adhesion [60]. In our previous study, we showed that
LL-37 inhibited cell adhesion by binding to cell-wall carbohy-
drates, e.g., glucan [21]. On the basis of our studies and those of
others, it appears that b-1,3-glucan is involved in C. albicans
adhesion to host cells. Our new results suggest that the cell-wall
glucan network may be interfered by LL-37 via the inhibition of
Xog1p exoglucanase activity (Fig. 4B and 4C). We thus
hypothesized that dysfunction of exoglucanase can not only alter
the glucan composition of the cell wall (unpublished data), but also
affect glycosylation of other cell wall proteins required for
adhesion, leading to impair cell adhesion.
Although the activity of Xog1p decreased in the presence of LL-
37, the mechanism responsible for the decrease has not been
delineated. Notably, two structural Xog1p loops have been
proposed as the sites that bind cell-wall glucan during remodeling
[61]. Interestingly, three of the four Xog1p sequences identified by
searches in CGD after biopanning (Fig. 2) are located near to these
Figure 6. EXG2 has no significant effect on C. albicans cell adhesion or cellular interaction with LL-37. (A) Construction of EXG2-deletion
strains was verified by PCR (upper panel) and RT-PCR (lower panel). The amplified products of ACT1 and EFB1 were used as positive controls. (B) The
levels of C. albicans adhesion to polystyrene were assayed by measuring reduced XTT. The relative adhesion of a mutant is expressed as a percentage
of that found for the wild type strain. Each result is the mean 6 SD of four independent assays. (C) Comparison of LL-37 binding to wild type and
EXG2-deletion strains. Each strain was mixed with BA-LL37 in PBS at 4uC overnight, and binding of LL-37 to the strains was measured by flow
cytometry. Each result is the mean 6 SD of two independent assays. (D) Exoglucanase activity assays for the wild type and EXG2-deletion strains. Cells
from logarithmic- or stationary-growth phase were collected, and glucanase activity in the cells and in cell extracts was assayed using the model
substrate PNPG. Each result is the mean 6 SD of three independent assays.
doi:10.1371/journal.pone.0021394.g006
strains. Overnight cultures were collected and assayed using PNPG as the substrate. All assays were carried out three times. The two-tailed Student’s
t-test was used to determine the statistical significance of the data; *, p,0.05; **, p,0.01. (C) Adhesion of C. albicans XOG1-mutant strains. Each strain
was suspended in RPMI-1640 medium and incubated at 37uC for 30 min in polystyrene wells. After washing, cells that remained in the wells were
assayed by XTT reduction. Each result is the mean 6 SD of four independent assays. The two-tailed Student’s t-test was used to determine the
statistical significance of the data; *, p,0.05; **, p,0.01. (D) Comparison of LL-37 binding to wild type, XOG1-deletion, and XOG1-reintegrated strains.
Each strain was individually mixed with BA-LL37 in PBS at 4uC overnight, and the binding of LL-37 to the cells was measured by flow cytometry using
streptavidin-conjugated 4,6-dichlorotriazinyl aminofluorescein. Each result is the mean 6 SD of two independent assays. (E) Exoglucanase activity in
cell extracts from various C. albicans strains. Logarithmically growing cultures were collected and assayed using PNPG. All assays were carried out
three times. The two-tailed Student’s t-test was used to determine the statistical significance of the data; *, p,0.05.
doi:10.1371/journal.pone.0021394.g005
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not found in any of the four Xog1p sequences (Fig. 2). If these
Xog1p sequences can indeed bind LL-37, then LL-37 may
indirectly reduce Xog1p activity by inducing a conformational
change rather than by binding to a site(s) involved in Xog1p
catalysis. Therefore, additional physical characterization of the
LL-37/Xog1p interaction(s) is necessary and is underway in our
laboratory.
Even when both XOG1 alleles had been deleted and the cells
were in the logarithmic-growth phase, neither the cellular
exoglucanase activity nor cell adhesion was completely abolished
(Fig. 5E, 5C, respectively). These results suggest that other cell-wall
enzymes or polysaccharides compensate by participating in cell-
wall remodeling [45,62], which might explain why cell adhesion
and exoglucanase activity were less affected in cells during
logarithmic growth (Fig. 5E) than when cells were in the stationary
phase (Fig. 5B). As deletion of XOG1 did not completely abolish
LL-37 binding (Fig. 5D), another protein(s) or polysaccharides
probably also binds LL-37. Three CWPs that might bind LL-37
were found by far-western blotting (Fig. 1B). Two have molecular
masses of 45,50 kDa, and one has a mass of ,60 kDa. However,
we focused on only Xog1p, which has a molecular mass of
,45 kDa, as it is primarily responsible for the polysaccharide
composition of the cell wall. The identification of other possible
LL-37-targeted protein(s) will be performed in the future.
In summary, we showed that LL-37 prevented C. albicans
colonization by inhibiting the attachment of C. albicans to
polystyrene and epithelial cell surfaces via interacting with
carbohydrates and/or cell-wall proteins. Using phage display, we
identified cell-wall Xog1p as a LL-37 binding target, which may
play a role in adhesion inhibition mediated by LL-37. We have
now shown that this inhibition may partially cause by LL-37
binding to Xog1p, followed by reducing Xog1p activity.
Consequently, cell-wall remodeling might be interfered. We also
showed that Xog1p itself is also involved in C. albicans adhesion
through direct or indirect ways. Thus, we proposed that if a
certain CWP is bound by LL-37, CWP is assumed to have
potential to involve in cell adhesion. Given our observations, LL-
37 may be a useful tool with which to screen for other CWPs
involved in C. albicans adhesion. Because the cells of higher
eukaryotes do not have a cell wall, Xog1p could perhaps be
efficaciously targeted by monoclonal antibodies or short peptides
to block fungal adhesion during infection.
Materials and Methods
Peptides and reagents
LL-37 (LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLV-
PRTES) and the biotinylated BA-LL37 were synthesized by
MDBio, Inc. (Taipei, Taiwan). The results of HPLC and mass
spectrometry showed that the peptides were 95% pure. All
reagents were from Sigma-Aldrich (St. Louis, Mo) unless otherwise
indicated.
C. albicans strains, growth media, and growth conditions
Table 1 lists C. albicans strains used in this study. The cells were
maintained at 280uC and plated onto YPD agar (1% yeast
extract, 2% Bacto-Peptone, 2% glucose, and 1.5% agar) before
each experiment. A single colony from a plate was inoculated in
YPD broth and incubated at 30uC overnight (,14 h). This culture
was then sub-cultured in YPD broth for ,2.5 h to reach
logarithmic-growth phase. For LL-37 treatment, cells were washed
twice with phosphate-buffered saline (PBS), collected by centrifu-
gation, and suspended in Gibco RPMI-1640 medium (Invitrogen,
Carlsbad, CA) or PBS.
LL-37/C. albicans–binding assay
The binding of LL-37 to C. albicans was assayed as described
[21,63]. Briefly, the CWPs were removed by proteinase K (1 mg/
ml) at 30uC for 1 h, then cells (6610
6) were mixed with 10-mg BA-
LL37 in 750-ml PBS and incubated at 4uC overnight. The extent
of binding was assessed by flow cytometry (FACSCalibur equipped
with a diode laser, excitation at 488 nm; BD Bioscience, San Jose,
CA) with SA-DTAF detection (3 mg/reaction; Jackson ImmunoR-
esearch, West Grove, PA). The fluorescence emission from the
cells was passed through an FL1 filter (515–545 nm), and the
fluorescence intensity was recorded. The amount of LL-37 bound
to XOG1 and EXG2 cells was normalized to mean fluorescence
index of the wild type strain and reported as percentages.
CWP extraction and western blotting
C. albicans cell-wall extracts were fractionated as described
[64,65], with modifications. Briefly, 3610
9 cells were incubated in
PRMI-1640 at 37uC for 30 min. The cells were washed twice with
PBS and then incubated in 50 mM Tris-HCl, pH 7.8, 1% b-
mercaptoethanol (b-ME) at 37uC for 30 min. The supernatant was
collected by centrifugation (1,0006 g) for 10 min and designated
the b-ME cell-wall fraction. The b-ME-treated cells were washed
with 1 M sorbitol and suspended in 1 M sorbitol, 0.1 M sodium
citrate, pH 5.8, 25 mM EDTA, and 2 U b-glucanase (49101;
Sigma-Aldrich) at 30uC for 1 h. This solution was centrifuged at
1,0006g for 10 min, and the supernatant was designated the b-
glucanase extract. Proteins from the two extracts were electro-
phoresed through SDS (MDBio, Inc.) 10% polyacrylamide gels
(40% acrylamide/bis solution; MDBio, Inc.) and then transferred
to polyvinylidene difluoride membranes (Pall Corporation, Port
Washington, NY).
After transfer of the proteins, the membranes were blocked with
3% non-fat milk at room temperature for 2 h. For Xog1p
detection, the membranes were probed with mouse monoclonal
anti-His6 (Roche Applied Science, Indianapolis, IN) or rat
Figure 7. Xog1p plays a role in the adhesion of C. albicans to
polystyrene. Inhibition of C. albicans adhesion to polystyrene by anti-
Xog1p. Wild-type C. albicans was incubated with the IgG-rich fractions
that had been purified from anti-Xog1p, pre-immune and anti-C.
albicans serum. Each result is the mean 6 SD of assays performed in
triplicate. The two-tailed Student’s t-test was used to determine the
statistical significance of the adhesion of anti-Xog1p treated vs. mock
cells was determined using Student’s t-test; *, p,0.05; **, p,0.01.
doi:10.1371/journal.pone.0021394.g007
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HRP (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) or goat
anti-rat IgG-HRP (Jackson ImmunoResearch). To detect LL-37-
binding proteins by far-western blotting, BA-LL37 (1.1 mM) in
0.1% PBST [PBS, 0.1% (v/v) Tween-20, without BSA or dried
milk] served as the primary probe, and HRP–conjugated
streptavidin (SA-HRP; Zymed Laboratories, San Francisco, CA)
was used for visualization with ECL kit reagents (PerkinElmer Life
Sciences, Wellesley, MA) according to the manufacturer’s
instructions.
Identification of LL-37-binding proteins by phage-display
biopanning
Biopanning was performed with a library generated by Ph.D.-
12
TM Phage Display Peptide Library reagents (New England
BioLabs, Ipswich, MA) according to the manufacturer’s instruc-
tions. LL-37 (15 mg in 150 ml 0.1 M NaHCO3, pH 8.6) was
coated onto wells of 96-well microtiter plates (Nunc
TM, Rochester,
NY) and incubated overnight at 4uC with gentle agitation. Each
well was filled with blocking buffer (0.1 M NaHCO3, pH 8.6,
5 mg/ml BSA, 0.02% NaN3) for 1 h at 4uC and then washed with
0.1% TBST [TBS, 0.1% (v/v) Tween-20]. For the first round of
panning, 10 ml of the phage suspensions (1.5610
11 virions in
100 ml of 0.1% TBST) was added to the LL-37-coated wells and
incubated for 1 h at room temperature with gentle agitation.
Unbound phages were discarded, and the wells were washed 10
times with 0.1% TBST. LL-37 samples (10 mg in 100 ml of TBS)
were added to the wells and incubated for 1 h at room
temperature to elute the bound phage. For the second and third
rounds of biopanning, the aforementioned procedures were
repeated, except that the eluates from the first and second rounds
were used as input for the second and third rounds, respectively. In
addition, the concentration of Tween-20 in the TBST-wash buffer
was increased to 0.5% (v/v).
After each round of biopanning, eluted phages were amplified
in and titered using E. coli ER2738. Samples of E. coli in Luria-
Bertani (LB, 20 ml) broth were infected with the eluted phages and
incubated for 4.5 h at 37uC. Cultures were centrifuged two times
(10,0006g) for 10 min at 4uC by transferring the supernatant to a
new tube after first centrifugation. To precipitate the phages, the
upper 80% of the supernatants was transferred to new tubes and
incubated with 1/6 volume of 20% (w/v) polyethylene glycol-
8000, 2.5 M NaCl at 4uC overnight. The solutions were
centrifuged at 10,0006 g for 15 min at 4uC, and the pelleted
phages were suspended in 1 ml TBS. The samples were
centrifuged at 10,0006g for 5 min at 4uC, and the supernatants
were precipitated as described above for 1 h at 4uC to isolate the
phages. Finally, the phages were harvested by centrifugation at
10,0006 g for 10 min at 4uC and suspended in 200 ml of TBS.
After centrifugation at 10,0006 g for 1 min at 4uC, the
supernatants were collected and used as the amplified phage
samples.
Eluates of biopanned and amplified phages that had been
serially diluted 10-fold starting with 10-ml volumes were each
added into 200 ml of mid-logarithmic–growth phase E. coli
ER2738 cultures. The infected E. coli cultures were each
suspended in top agarose (LB broth, 0.7% agarose) and poured
onto LB agar plates that contained 50 mg/ml isopropyl b-D-
thiogalactoside (MDBio, Inc.), 40 mg/ml 5-bromo-4-chloro-3-
indolyl-b-D-galactoside (MDBio, Inc.). The plates were incubated
overnight at 37uC. Phage titers were calculated by counting the
number of plaques and multiplying by the serial-dilution factor.
Characterization of cloned, LL-37-binding phage
After three rounds of biopanning, sequencing templates were
rapidly purified, and the sequences of selected LL-37-binding
peptides were determined according to the manufacturer’s
instructions (New England BioLabs) and [66]. Twenty isolated
blue plaques were transferred to E. coli ER2738 cultures (1 ml
each). The cultures were incubated at 37uC for 4.5 h and
centrifuged at 10,0006 g for 30 sec. The supernatants were
centrifuged again under the same conditions, and 500-ml of each
supernatant was added to 200-ml 20% (w/v) polyethylene glycol-
8000, 2.5 M NaCl. After incubation at room temperature for
10 min, the supernatants were centrifuged twice for 10 min, and
the pellets were suspended in 100 ml of 10 mM Tris-HCl, pH 8.0,
1 mM EDTA, 4 M NaI, after which 250 ml absolute ethanol was
added. Phage DNA was collected by a 10-min centrifugation at
10,0006 g at room temperature, washed with 70% ethanol, and
dissolved in 30 mlH 2O. The isolated DNA was sequenced using
the 296 gIII sequencing primer (59-CCCTCATAGTTAGCG-
TAACG-39).
Table 1. Strains of Candida albicans used in this study.
Strain Parent Genotype Source
SC5314 Wild type Gillum et al., 1984
PWTXA7 SC5314 XOG1/xog1D::SAT1-FLIP This work
PWTXB73 PWTXA7 XOG1/xog1D::FRT This work
PWTXC7311 PWTXB73 xog1D::FRT/xog1D::SAT1-FLIP This work
PWTXD73115 PWTXC7311 xog1D::FRT/xog1D::FRT This work
PWTXE3 PWTXD73115 xog1D::XOG1-SAT1-FLIP/xog1D::FRT This work
PWTXF39 PWTXE3 xog1D::XOG1-FRT/xog1D::FRT This work
PWTXG3918 PWTXF39 xog1D::XOG1-FRT/xog1D::XOG1-SAT1-FLIP This work
PWTXH39184 PWTXG3918 xog1D::XOG1-FRT/xog1D::XOG1-FRT This work
PWTEA7 PWTXH39184 EXG2/exg2D::SAT1-FLIP This work
PWTEB71 PWTEA7 EXG2/exg2D::FRT This work
PWTEC711 PWTEB71 exg2D::FRT/exg2D::SAT1-FLIP This work
PWTED7113 PWTEC711 exg2D::FRT/exg2D::FRT This work
doi:10.1371/journal.pone.0021394.t001
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sequenced was added into a 5-ml E. coli ER2738 culture to be
amplified again as described above. ELISA plates were coated
with LL-37 and blocked with blocking buffer before adding phage.
Phages were prepared as four-fold serial dilutions in 200 ml 0.1%
TBST per well, with 2610
10 virions in the first well and 1.2610
6
virions in the last well. After incubation and washing as described
for biopanning, mouse monoclonal anti-M13 (Santa Cruz
Biotechnology, Inc.) was diluted 1:2,000 in 200 ml blocking buffer
and added into each well. The plates were incubated at room
temperature for 1 h and then washed six times with 0.1% TBST.
HRP-conjugated anti-mouse IgG, diluted as described above, was
added into the wells, which were then incubated for 1 h at room
temperature. Each well was then washed six times with 0.1%
TBST. Binding was detected using 3,39,5,59-tetramethylbenzidine
with the absorbance at 450 nm.
Searching for the potential LL-37 interacting proteins
from Candida Genome Database (CGD)
The consensus pattern identified from phage-display biopan-
nings, WHWXWWXWXW, was used as a reference segment, and
transformed to ‘‘JHWXJJXJXJ’’, where J means any hydrophobic
residue, and X represents any amino acid residue. The
transformed pattern was input into PatMatch of the CGD. In
order to increase the matching hits, any of the continuous 4
residues matched with the sequences in CGD were chosen. Then,
the chosen sequences representing proteins located at cell wall
were particularly selected. As results, the phage clones has 3
perfect matches to the peptide segments of Xog1p, including
Xog1p90–93, Xog1p134–140, and Xog1p398–403. In the comparison
of the whole Xog1p sequence with the consensus pattern, another
segment, Xog1p108–112, was also identified as a potential region for
LL-37 binding.
ELISA for LL-37/Xog190–115 association
The extent of binding of Xog190–115 (residues 90–115 from
Xog1p, YHWTQTLGKEAASRILQKHWSTWITE), which was
synthesized by MDBio, Inc., to LL-37 was determined by ELISA.
Xog190–115 (5 mg) was coated onto the wells of 96-well microtiter
plates. After wells were blocked and washed as for the biopanning
procedure, BA-LL37 (0.01–5 mg/ml in 100 ml of 0.1% TBST) was
added to individual wells. After incubation and washing, the BA-
LL37 that had bound Xog190–115 was detected using SA-HRP and
3,39,5,59-tetramethylbenzidine. The absorbance at 450 nm was
measured using a VICTOR3 Multilabel plate reader (PerkinEl-
mer, Inc.).
Expression, purification, and refolding of recombinant
Xog1p
XOG1 was amplified via PCR from C. albicans SC5314 genomic
DNA using the primers 59-ATATCATATGGGACATAATG-
TTGCTTGG-39 and 59-ATATCTCGAGGTGAAAGCCACA-
TTGGTTTG-39 (the NdeI and XhoI sites are underlined and
doubly underlined, respectively). The DNA fragment carrying
XOG1 was isolated by digestion with NdeI and XhoI, ligated into
pGEM-T Easy, sequenced, and cloned into pET23a(+) (pET23-
XOG1).
For the expression of rXog1p, pET23-XOG1 was transformed
into E. coli BL21(DE3)pLysS. A colony was added into 15 ml LB
broth containing 100 mg/ml carbenicillin and 50 mg/ml chloram-
phenicol, and the culture was incubated at 37uC and 200 rpm
overnight. This culture was added into 500 ml of LB broth that
also contained carbenicillin and chloramphenicol at 37uC and
incubated until its OD600 reached 0.5–0.8. rXog1p expression was
induced with isopropyl b-D-thiogalactoside (0.5 mM, final con-
centration), and the culture was incubated for an additional 5 h.
Cell pellets were harvested by centrifugation, suspended in 15-ml
PBS, and sonicated. The insoluble fraction was isolated by
centrifugation at 10,0006g at 4uC for 10 min.
The inclusion bodies contained in the insoluble fraction were
dissolved in 10 ml binding buffer (6 M urea, 0.5 M NaCl, 20 mM
Tris-HCl, pH 7.5) and incubated overnight at 4uC. After
centrifugation at 10,0006 g for 30 min at 4uC, the supernatant
was processed using Ni
2+-chelating chromatography (Promega,
Madison, WI). Unbound proteins were removed sequentially with
binding buffer and then with 10 mM imidazole in binding buffer.
rXog1p was eluted with a linear gradient of 50–300 mM
imidazole in binding buffer. The purity of rXog1p was assessed
after electrophoresis through an SDS 12% polyacrylamide gel and
staining with Coomassie Blue (data not shown).
To refold rXog1p, reduced glutathione (80 mM, final concen-
tration) was added into a solution of purified rXog1p, which was
then incubated at room temperature for 30 min. Denatured
rXog1p was refolded by rapid dilution (100 fold) into 0.1 M Tris-
HCl, pH 7.5, containing 10% glycerol, 1 mM EDTA, 0.5 M L-
arginine, protease inhibitors (1 mM phenylmethylsulfonyl fluoride,
40 mM benzamidine, 40 mg/ml aprotinin, 20 mg/ml leupeptin,
20 mM 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride),
and oxidized glutathione so that the final reduced/oxidized
glutathione ratio was 4:1. The protein was incubated at 4uC with
very slow stirring for 24 h, and then was concentrated using a
Centricon system (10K MWCO, Millipore, Billerica, MA) at 4uC.
The final protein concentration was determined using BCA assay
reagents (Thermo Scientific).
Preparation and purification of polyclonal antibodies
against C. albicans Xog1p
All animal studies were approved by the Institutional Animal
Care and Use Committees of Animal Technology Institute
Taiwan (approval number 10003). Two female Sprague-Dawley
rats (BioLasco Taiwan Co., Ltd.) were injected subcutaneously
with 200 ml of an emulsion that contained 100 mg rXog1p in PBS
and an equal volume of Freund’s complete adjuvant (primary
immunization) or an equal volume of Freund’s incomplete
adjuvant (booster immunization). Beginning 2 weeks after primary
immunization, four boosters were given at 3-week intervals over 3
months. Serum from each immunized rat was isolated by
centrifugation at 4,0006 g for 10 min. Pre-immune serum was
collected from each un-immunized rat, pooled, and processed in
the same manner.
Anti-Xog1p and mock antisera were further purified using
MontageH Ab Purification kit reagents (Millipore). The Xog1p
antiserum was filtered through a 0.2-mm syringe filter to remove
debris and then mixed 1:1 (v/v) with binding buffer A (1.5 M
glycine/NaOH buffer, 3 M NaCl, pH 9.0). A spin column was
fabricated using a centrifuge tube that was filled with protein A
medium (PROSE-A, Millipore); the column was equilibrated with
10 ml binding buffer A by centrifugation at 5006g for 5 min. The
filtered serum (10 ml) was then added into the spin column and
centrifuged at 1506 g for 20 min at 4uC. After removing the
supernatant, another 10 ml of filtered serum was loaded and
centrifuged at 1506g for 20 min at 4uC. Then, the spin column
was washed with binding buffer A to remove unbound
contaminants and centrifuged at 5006g for 2 min at 4uC. Anti-
Xog1p was eluted with 0.2 M glycine/HCl, pH 2.5, and the
eluate was immediately neutralized with 1 M Tris-HCl, pH 9.0.
Eluted anti-Xog1p was concentrated using an AmiconH Ultra-30K
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PLoS ONE | www.plosone.org 11 June 2011 | Volume 6 | Issue 6 | e21394system (Millipore). Finally, NaN3 [0.1% (w/v), final percentage]
and glycerol [50% (v/v), final percentage] were added, and the
concentrated antiserum was stored at 220uC.
Interaction of LL-37 and rXog1p
Streptavidin-agarose (10 ml), BA-LL37, and rXog1p in 500 ml
TBS were gently shaken at room temperature for 2 h and then
pelleted. The pellets were washed six times with 1 ml of TBS.
After the last wash, the pellets were suspended in sample buffer
that contained SDS and b-ME and heated at 100uC for 10 min.
The LL-37/rXog1p complexes were identified after electropho-
resis through Tricine SDS 15% polyacrylamide gels and staining
with Coomassie Blue.
C. albicans adhesion to polystyrene
C. albicans adhesion to uncoated, flat-bottom, polystyrene wells
of 24-well plates (Orange Scientific, Braine-I’Alleud, Belgium) was
as described [21,67,68]. The cells were harvested, washed with
PBS, and suspended in RPMI-1640 medium at a density of
,6610
7 cells/ml. For competition assays, LL-37 was mixed with
Xog190–115 or rXog1p and the cells. To assess the effect of gene
deletion on cell adhesion, the C. albicans strains listed in Table 1
were used. To assess the effect of Xog1p antiserum on cell
adhesion, different concentrations of anti-Xog1p serum were
added to cells. Rabbit polyclonal antibody that recognizes
numerous proteins in a soluble C. albicans extract (Biodesign
International, Saco, ME) was also used. Next, 250 ml of the cell
suspensions were each transferred into a well of a 24-well flat-
bottom plate and incubated at 37uC for 30 min at 100 rpm. The
metabolic activity of the sessile cells was then measured by
detecting the reductive adduct of XTT [69]. Briefly, cells were
washed three times with PBS to remove floating cells. The
remaining cells were incubated with 300 ml XTT (1 mg/ml) and
0.6 ml menadione (1 mM) in PBS per well at 37uC for 20 min. The
absorbance at 490 nm for each sample was measured using a
VICTOR3 Multilabel plate reader. The relative percentage of
cells was calculated as: mean absorbance of [each treatment
(XOG1, EXG2 mutant strains or anti-Xog1p, anti-C. albicans
serum)]/[no treatment (wild type or pre-immune serum)]6100%.
All assays were performed in duplicate or triplicate and repeated
two to three times.
Glucanase activity assay
Cells for the b-glucanase activity assay were prepared as
described [45]. Briefly, 1610
9 cells were centrifuged and the
supernatant was removed. The pellet was suspended in 500 mlo f
50 mM sodium acetate, pH 5.5. In addition, a b-ME-treated cell-
wall extract was prepared as described above but was then
suspended in 500 ml of 50 mM Tris-HCl, pH 7.8, 1% b-ME. A
200-ml sample of cells or a 200-ml sample of the cell-free extract
were separately transferred to two Eppendorf tubes. A solution of
PNPG (5 mg/ml) in 50 mM sodium acetate, pH 5.5 (200 ml) was
added into one of the tubes that contained cells or one that
contained cell-free extract. Duplicate samples to which PNPG was
not added served as background control of each sample. In
addition, the buffer same as that in the test samples was also
included as a blank in this assay, including one tube with PNPG
and the other without PNPG. All samples were incubated at 37uC
for 3 h, and then 1 ml of 1 M Na2CO3 was added to each tube to
stop the reactions. Hydrolysis of PNPG was measured spectro-
photometrically at 410 nm, and the activity of each sample after
PNPG hydrolysis, absorbance of PNPG-free sample was subtract-
ed from absorbance of PNPG-containing sample. The relative
glucanase activity was calculated as: [(absorbance for each LL-37-
treated or mutant strain)/(absorbance for the untreated or wild
type sample)]6100%. The assays were performed three to four
times for each strain and treatment.
Cell susceptibility to agents that interrupt cell-wall
integrity
Cells were grown as described above and suspended in RPMI-
1640 at 1.2610
7 cells/ml. After incubation with different
concentrations of LL-37, 10-ml cell samples that had undergone
10-fold serial dilutions were spotted onto YPD agar plates that
contained 10 mg/ml calcofluor white or 15 mg/ml congo red. Cell
viability was recorded after incubation at 30uC for 20 h. This
assay was performed independently at least three times.
Construction of C. albicans mutant strains and Southern
blotting
To generate the C. albicans XOG1- and EXG2-null strains, the
SAT1-flipper method was used [48]. An XOG1-deletion cassette
was constructed as follows: an ApaI-XhoI fragment containing a C.
albicans XOG1 upstream sequence (positions 2726 to 2334) was
amplified using SC5314 genomic DNA and the primers XOG1-1
[59-ATATGGGCCCCAAACACAATCGCAAATTGA-39] and
XOG1-2 [59- ATATCTCGAGATTGCAAGCGACTTGGTC-
TT-39] (the ApaI and the XhoI sites are singly and doubly
underlined, respectively). A fragment that contained an XOG1
downstream region from positions +1761 to +2241 was amplified
with the primers XOG1-3 [59-ATATCCGCGGTGCTTTG-
TTCTTGATTGCTG-39] and XOG1-4 [59-ATATGAGCTC-
CACATTGCCTGAAGTCGTTG-39] (the SacII and SacI sites are
underlined and double underlined, respectively). The XOG1
upstream and downstream fragments were cloned into pSFS2A
(a kind gift from Professor J. Morschhauser, University of
Wurzburg, Germany) to generate pXOG1M2. For EXG2 deletion,
a DNA fragment containing a region upstream of C. albicans EXG2
was amplified with primers EXG2-1 [59-ATATGGGCCC-
GAAGCCGAATCCAAACAAAA-39] and EXG2-2 [59-ATAT-
CTCGAGTGACAGTTGGTGCTCCCTTA-39] (the ApaI and
the XhoI sites are underlined and doubly underlined, respectively).
A fragment containing the C. albicans EXG2 downstream region
was amplified with primers EXG2-3 [59-ATATCCGCG-
GATCCGGTGTTGTTGGTTCAT-39] and EXG2-4 [59-
ATATGAGCTCCCTTTTTGTTTGGGGTAGCA-39] (the Sa-
cII and SacI sites are underlined and double underlined,
respectively). Both DNA fragments were cloned into pSFS2A to
generate pEXG2M2. The DNA fragments carrying the regions
that flanked XOG1 or EXG2 and the SAT1 flipper cassette were
independently isolated from pXOG1M2 or pEXG2M2, respec-
tively, by digestion with ApaI and SacI. Following transformation
into C. albicans SC5314, each cassette was integrated into the
chromosome by homologous recombination of the XOG1 or EXG2
flanking sequences. Transformants were selected for nourseothri-
cin resistance and subsequently grown for 2 days in YPM (1%
yeast extract, 2% Bacto-peptone, 2% maltose) medium to induce
recombinase, which excised the SATI marker. The remaining
intact XOG1 and EXG2 alleles in the XOG1/xog1D or EXG2/exg2D
strains were then each inactivated. Two independently generated
heterozygous and homozygous XOG1- and EXG2-deletion strains
were used initially in the cell adhesion assays, and then only one
clone of each was used for further studies.
For re-integration of XOG1 into the original loci of the xog1D/
xog1D strain, the ApaI- XhoI fragment that contained the complete
XOG1 gene and the 0.33-kb upstream flanking sequence of XOG1
was amplified with the primers XOG1-1 and XOG1-5 [59-
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sites is double underlined) and substituted for the XOG1 upstream
flanking sequence in pXOG1M2 to generate plasmid pXOG1M3.
Sequential reintegration of XOG1 was also performed by the
SAT1-flipper method. Strain construction was verified by PCR
and Southern and western blotting using standard methods [70].
RNA isolation and reverse transcriptase-PCR
C. albicans cells were grown in YPD overnight. Then total RNA
was isolated using TRI reagentH (Ambion, Inc.), and the RNA was
treated with TURBO
TM DNase (Ambion, Inc.) according to the
manufacturer’s instructions. Total RNA (1 mg) was reverse
transcribed into single-stranded cDNA with M-MLV reverse
transcriptase (Promega) and oligo(dT)18 (MDBio, Inc.). XOG1 or
EXG2 cDNA and ACT1 or EFB1 cDNA (as internal controls) were
PCR amplified with the primers 59-CAGTTGACGAATAT-
CACTGGACA-39 (forward) and 59-AATATCCAACAATGG-
TTGACAGG-39 (reverse) for XOG1, and 59-CAGTTACGG-
TCTGTGTCCAGTGTAG-39 (forward) and 59- GGACACA-
CATGGAGGTTTAAAGAAG-39 (reverse) for EXG2. The prim-
ers used for ACT1 were 59-GGCTGGTAGAGACTTGAC-
CAACCATTTG-39 (forward) and 59-GGAGTTGAAAGTGG-
TTTGGTCAATAC-39 (reverse), and for EFB1 were 59-ATT-
GAACGAATTCTTGGCTGAC-39 (forward) and 59-CATC-
TTCTTCAACAGCAGCTTG-39 (reverse). Each primer was
0.5 mM. Each reaction mixture was first denatured at 95uC for
10 min. The PCR program consisted of 30 cycles of 95uC for
30 sec, 55uC for 30 sec, and 72uC for 30 sec, followed by a final
10-min incubation at 72uC. PCR products were visualized by
SYBRH Safe (Invitrogen) staining after agarose gel electrophoresis.
Statistical analysis
Data were assessed for statistical significance by the two-tailed
Student’s t-test.
Accession numbers
Information concerning the genes/proteins used in this study
can be obtained at the Candida Genome Database (http://www.
candidagenome.org). The genes and their corresponding open
reading frame numbers (in parentheses) are: XOG1 (orf19.2990)
and EXG2 (orf19.2952).
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